CAS: 36894-69-6; Labetalol

该化合物是一种主要用于治疗高血压和高血压的药物,被归类为具有阿尔法-1阻塞作用的非选择性乙阻塞剂,通过降低心跳率和放松血管,有助于降低血压.拉贝诺醇的化学配方为C19H24N2O3, 其结构复杂,包括苯丙基氢氧基,乙醚联系和二级甲胺.拉贝诺醇以其独特的双重作用而著称,它能够有效地管理高血压,同时最大限度地减少与传统乙型阻塞剂通常相关的一些副作用.它通常通过口服或静脉注射方式进行,其常见副作用可能包括眩晕,疲劳和胃肠扰动.由于其药理学特征,在诸如孕妇等某些人群中,青贝罗热素往往被选用于管理高血压.临床研究中已经充分记录了它的安全性和功效,因此它是治疗心血管病症的一个有价值的选择.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

1-phenyl-3-butanol 5-(2-bromoacetyl)-2-hydroxybenzamide acetyl>benzamide2-hydroxy-5-acetylbenzamide labetaol(RS)-1-methyl-3-phenylpropylamine 5-formyl-2-hydroxy-benzamide (S,R)-labetalol *)>-2-hydroxy-5-ethyl>benzamide*)-2-hydroxy-5-1-hydroxy-2-(1-methyl-3-phenylpropyl)aminoethylbenzamide

合成工艺路线路线简述

    4-苯基-2-丁醇置于palladium 10% On Activated Carbon,氢气,Potassium Carbonate,三乙胺体系中,用 甲醇,二氯甲烷,乙腈 用作溶剂,-10.0~81.0 °C,500.01 Kpa 条件下,反应 8.0H,反应生成拉贝洛尔
    参考文献:一种盐酸拉贝洛尔的制备方法
    标题:一种盐酸拉贝洛尔的制备方法
    摘要:本发明提供了一种盐酸拉贝洛尔的制备方法,属于医药技术领域.本发明提供的制备方法,以5‑卤代乙酰基水杨酰胺作为起始原料与苄胺进行亲核取代反应,然后与3‑卤代丁基苯进行亲核取代反应(或者是与3‑羟基丁基苯和对甲基苯磺酰氯酯化反应产物进行胺酯交换反应),再进行催化氢化反应反应后成盐,得到盐酸拉贝洛尔.本发明提供的制备方法,采用苄胺替代二苄胺,原料的原子利用率高,对环境友好,体现了绿色化学的原子经济性;胺酯交换反应选择性高,所得产物直接用于下一步反应;采用一步法脱除保护剂和还原羰基缩短了工艺路线;制备方法操作简便且稳定性和可控性高,生产成本高,产率高,适宜工业化生产.

    海关参考信息

    专利信息


    专利号:US-9353057-B2
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
    发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
    权利人:XENOPORT INC
    摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-10973847-B2
    优先权日:2017-06-30
    标题 :Core-to-surface polymerization for the synthesis of star polymers and uses thereof
    发明人:JOHNSON JEREMIAH A; GOLDER MATTHEW R
    权利人:MASSACHUSETTS INST TECHNOLOGY
    摘要:Disclosed are methods, compositions, reagents, systems, and kits to prepare star polymers, as well as compositions and uses thereof. Various embodiments show that synthesis of these polymers contain low metal concentration to provide polymers for diverse biomedical applications including in vivo applications.

    专利号:US-5442118-A
    优先权日:1994-04-22
    标题 :Asymmetric synthesis of (R)- and (S)-arylethanolamines from iminoketones
    发明人:GAO YUN; HONG YAPING; ZEPP CHARLES M
    权利人:SEPRACOR INC
    摘要:A method for the enantioselective reduction of an alpha -iminoketone to an alpha -aminoalcohol is disclosed. The method utilizes a borane reducing agent as the reducing agent and a chiral 1,3,2-oxazaborole as the catalyst. The method is applied to the synthesis of R-albuterol from methyl 5-acetylsalicylate in high yield and high optical purity.

    专利号:US-2008287407-A1
    优先权日:2003-12-10
    标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
    发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

    专利号:US-2006000773-A1
    优先权日:2003-03-07
    标题:Process for the synthesis of a chromatographic phase
    发明人:GLENNON JEREMY; HEALY LIAM
    权利人:GLENNON JEREMY; HEALY LIAM
    摘要:A process for the synthesis, delivery or deposition or localisation of a chromatographic phase, especially for chromatographic separation or solid phase extraction, comprises introducing a chemical moiety to a support using a supercritical fluid such as supercritical carbon dioxide.
    建德市紫山湾精细化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zishanchem.com
    企业联系电话:013506812652👤
    📞建德市紫山湾精细化工有限公司 ⚠️参考联系方式
    联系人:蔡国忠
    电话:013506812652
    手机:13506812652
    传真:86-571-64155118
    邮箱:jdzs@zishanchem.com
    通信地址: 浙江省建德市新安江
    邮编: 311619
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省建德市新安江
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Lang Y, Fu F, Sun D, Xi C, Chen F. Labetalol Prevents Intestinal Dysfunction Induced by Traumatic Brain Injury. PLoS One. 2015 Jul 17;10(7):e0133215. doi: 10.1371/journal.pone.0133215. eCollection 2015.
    2: Fischer JH, Sarto GE, Hardman J, Endres L, Jenkins TM, Kilpatrick SJ, Jeong H, Geller S, Deyo K, Fischer PA, Rodvold KA. Influence of gestational age and body weight on the pharmacokinetics of labetalol in pregnancy. Clin Pharmacokinet. 2014 Apr;53(4):373-83. doi: 10.1007/s40262-013-0123-0.
    3: Liu-DeRyke X, Levy PD, Parker D Jr, Coplin W, Rhoney DH. A prospective evaluation of labetalol versus nicardipine for blood pressure management in patients with acute stroke. Neurocrit Care. 2013 Aug;19(1):41-7. doi: 10.1007/s12028-013-9863-9. doi: 10.1007/s00228-012-1428-x. Epub 2012 Oct 23. doi: 10.1186/cc10289. Epub 2011 Jun 27.

    合成参考文献


    参考文献:10.4061/2011/268370
    摘要:Dalal P, Phadke G, Gill A, Tarwater K, Misra M, Pele N, Odum B. A Patient with Hemoptysis and Renal Failure. International Journal of Hypertension. 2011;2011():1–3. doi: 10.4061/2011/268370.
    参考文献:10.4061/2011/495349
    摘要:Katholi RE, Couri DM. Left Ventricular Hypertrophy: Major Risk Factor in Patients with Hypertension: Update and Practical Clinical Applications. International Journal of Hypertension. 2011;2011():1–10. doi: 10.4061/2011/495349.
    参考文献:10.4103/0974-2700.82221
    摘要:Lentini S, Perrotta S. Aortic dissection with concomitant acute myocardial infarction: From diagnosis to management. J Emerg Trauma Shock. 2011 Apr;4(2):273–8.
    参考文献:10.1007/s11940-011-0138-5
    摘要:Kaw R, Gali B, Collop NA. Perioperative Care of Patients with Obstructive Sleep Apnea. Current Treatment Options in Neurology. 2011 Jul 19;13(5):496. doi: 10.1007/s11940-011-0138-5.
    参考文献:10.1002/elps.201000630
    摘要:Yu T, Du Y, Chen B. Evaluation of clarithromycin lactobionate as a novel chiral selector for enantiomeric separation of basic drugs in capillary electrophoresis. Electrophoresis. 2011 Jul;32(14):1898–905. doi: 10.1002/elps.201000630.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知